XM Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Brown University spinoff developing tissue repair and regeneration therapies for multiple chronic disorders affecting millions of ageing patients. Our scalable 3D organoid culture platform generates non-immunogenic human Extracellular Matrix particles that do not contain cells. Once injected, they engraft locally and lead to significant fibrosis reduction, increased angiogenesis, and improved organ function. Initial preclinical proof of concept available in myocardial infarction with additional, non-cardiac indication in progress. Our business model is partnering-enabled to facilitate clinical development, commercialization, and partnership(s). We are currently completing a seed round of funding.
Address
ProvidenceRhode Island
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}